Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 2,142 shares at $160.29 ($343K) on 2022-08-15, disclosed to the SEC on 2022-08-17.
Seasonal sale ($343k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.86 | 142 | $22K | 6.5% |
| 2 | $160.29 | 2,000 | $321K | 93.5% |
| Total | $160.06 avg | 2,142 | $343K | 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |